These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30333933)

  • 1. Managing Tumor Lysis Syndrome in the Era of Novel Cancer Therapies.
    McBride A; Trifilio S; Baxter N; Gregory TK; Howard SC
    J Adv Pract Oncol; 2017; 8(7):705-720. PubMed ID: 30333933
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents.
    Cheson BD; Heitner Enschede S; Cerri E; Desai M; Potluri J; Lamanna N; Tam C
    Oncologist; 2017 Nov; 22(11):1283-1291. PubMed ID: 28851760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review.
    Howard SC; Trifilio S; Gregory TK; Baxter N; McBride A
    Ann Hematol; 2016 Mar; 95(4):563-73. PubMed ID: 26758269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review.
    Coiffier B; Altman A; Pui CH; Younes A; Cairo MS
    J Clin Oncol; 2008 Jun; 26(16):2767-78. PubMed ID: 18509186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review.
    Salter B; Burns I; Fuller K; Eshaghpour A; Lionel AC; Crowther M
    Eur J Haematol; 2022 Aug; 109(2):166-181. PubMed ID: 35531791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome.
    Mughal TI; Ejaz AA; Foringer JR; Coiffier B
    Cancer Treat Rev; 2010 Apr; 36(2):164-76. PubMed ID: 20031331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Lysis Syndrome.
    Williams SM; Killeen AA
    Arch Pathol Lab Med; 2019 Mar; 143(3):386-393. PubMed ID: 30499695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of tumour lysis syndrome with targeted therapies and the role of rasburicase.
    Bose P; Qubaiah O
    J Clin Pharm Ther; 2011 Jun; 36(3):299-326. PubMed ID: 21501203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and management of tumor lysis syndrome in adults with malignancy.
    Sarno J
    J Adv Pract Oncol; 2013 Mar; 4(2):101-6. PubMed ID: 25031988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour lysis syndrome: new therapeutic strategies and classification.
    Cairo MS; Bishop M
    Br J Haematol; 2004 Oct; 127(1):3-11. PubMed ID: 15384972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies.
    McBride A; Westervelt P
    J Hematol Oncol; 2012 Dec; 5():75. PubMed ID: 23237230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing management of tumor lysis syndrome in adults with hematologic malignancies.
    Michallet AS; Tartas S; Coiffier B
    Support Cancer Ther; 2005 Apr; 2(3):159-66. PubMed ID: 18628166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress.
    Matuszkiewicz-Rowinska J; Malyszko J
    Kidney Blood Press Res; 2020; 45(5):645-660. PubMed ID: 32998135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase.
    Alakel N; Middeke JM; Schetelig J; Bornhäuser M
    Onco Targets Ther; 2017; 10():597-605. PubMed ID: 28203093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome.
    Jeon YW; Kwak DH; Park SS; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):595-603. PubMed ID: 28711571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rasburicase: a new approach for preventing and/or treating tumor lysis syndrome.
    Bessmertny O; Robitaille LM; Cairo MS
    Curr Pharm Des; 2005; 11(32):4177-85. PubMed ID: 16375739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Tumor Lysis Syndrome and Metastatic Melanoma.
    Kelkar N; Wang J
    Cureus; 2021 Sep; 13(9):e18108. PubMed ID: 34692319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Lysis Syndrome in Patients With Hepatocellular Carcinoma: A Systematic Review of Published Case Reports.
    Chou JW; Cheng KS; Akella T; Lee CC; Ju T
    Cureus; 2021 Oct; 13(10):e19128. PubMed ID: 34858764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Review of Tumor Lysis Syndrome Associated With Colorectal Cancer.
    Ansari Z; Findakly D; Wang J
    Cureus; 2020 May; 12(5):e8257. PubMed ID: 32596075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.
    Cairo MS; Coiffier B; Reiter A; Younes A;
    Br J Haematol; 2010 May; 149(4):578-86. PubMed ID: 20331465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.